Literature DB >> 11275716

Bulbar urethral stricture repair with buccal mucosa graft urethroplasty.

A Meneghini1, A Cacciola, L Cavarretta, G Abatangelo, P Ferrarrese, A Tasca.   

Abstract

OBJECTIVES: Evaluation of the use of buccal mucosa graft as single-stage urethral reconstruction in an adult population with a stenosis of the bulbar urethra.
METHODS: In our Department between April 1996 and February 1999, 20 patients with bulbar urethra stenosis underwent single-stage urethroplasty using a buccal mucosa graft. Mean age of patients was 52 years (range 14-70). The etiology of urethral stricture was inflammation (4 cases), iatrogenic (5 cases) and idiopathic (11 cases). A ventral onlay patch (mean length 3.6 cm, range 2.5-5) was employed in all cases.
RESULTS: During the follow-up (median 13 months, range 6-28) the overall success rate was 80%. The success rate was 75% for inflammatory strictures, 80% for iatrogenic strictures and 81% for strictures of unknown etiology.
CONCLUSIONS: Although longer follow-up is needed, free graft urethroplasty with buccal mucosa graft represents a simple surgical option which has produced encouraging results. This is probably due to the quality of the tissue employed which at present seems to represent the first-choice solution in selected cases.

Entities:  

Mesh:

Year:  2001        PMID: 11275716     DOI: 10.1159/000052450

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  3 in total

1.  [Oral mucosa for reconstructive urethral surgery].

Authors:  R Mayr; A Pycha
Journal:  Urologe A       Date:  2013-05       Impact factor: 0.639

2.  One-stage urethral reconstruction using colonic mucosa graft: an experimental and clinical study.

Authors:  Yue-Min Xu; Yong Qiao; Ying-Long Sa; Jiong Zhang; Hui-Zhen Zhang; Xin-Ru Zhang; Deng-Long Wu; Rong Chen
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  Results of Use of Tissue-Engineered Autologous Oral Mucosa Graft for Urethral Reconstruction: A Multicenter, Prospective, Observational Trial.

Authors:  Gouya Ram-Liebig; Guido Barbagli; Axel Heidenreich; Dirk Fahlenkamp; Giuseppe Romano; Udo Rebmann; Diana Standhaft; Hermann van Ahlen; Samer Schakaki; Ulf Balsmeyer; Maria Spiegler; Helmut Knispel
Journal:  EBioMedicine       Date:  2017-08-16       Impact factor: 8.143

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.